Miv Therapeutics, Inc. (IVT) Reports Q3 EPS of $0.06

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of $0.06. Revenue for the quarter came in at $50.89 million.

GUIDANCE:

Miv Therapeutics, Inc. sees FY2021 EPS of ($0.20)-($0.16).

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13